Log in

Vascular Biogenics Earnings Date, Estimates & History

0.00 (0.00 %)
(As of 09/25/2020 12:00 AM ET)
Today's Range
Now: $1.14
50-Day Range
MA: $1.26
52-Week Range
Now: $1.14
Volume46,299 shs
Average Volume446,770 shs
Market Capitalization$47.80 million
P/E RatioN/A
Dividend YieldN/A


Vascular Biogenics (NASDAQ:VBLT) Earnings Information

Vascular Biogenics last posted its earnings results on August 13th, 2020. The biopharmaceutical company reported ($0.14) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.14). The firm had revenue of $0.16 million for the quarter, compared to the consensus estimate of $0.19 million. Vascular Biogenics has generated ($0.54) earnings per share over the last year. Vascular Biogenics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 12th, 2020 based off prior year's report dates.

Vascular Biogenics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Vascular Biogenics (NASDAQ:VBLT) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20201($0.15)($0.15)($0.15)

Vascular Biogenics (NASDAQ VBLT) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/13/20206/30/2020($0.14)($0.14)($0.14)$0.19 million$0.16 millionTranscript
5/14/20203/31/2020($0.17)($0.15)($0.15)$0.19 million$0.37 millionTranscript
3/19/202012/31/2019($0.13)($0.16)($0.16)$0.18 million$0.13 millionTranscript
11/14/2019Q3($0.14)($0.14)($0.14)$0.24 million$0.08 millionTranscript
8/13/2019Q2($0.13)($0.13)($0.13)$0.25 million$0.14 millionN/A
5/15/20193/31/2019($0.06)($0.12)($0.12)$2.30 million$0.22 millionN/A
3/28/201912/31/2018($0.17)($0.10)($0.10)$0.30 million$0.14 millionTranscript
11/20/2018Q3($0.12)($0.15)($0.15)$0.30 million$0.10 millionN/A
8/16/20186/30/2018($0.18)($0.13)($0.13)$0.30 million$0.18 millionTranscript
5/17/2018Q1($0.21)($0.24)($0.24)$0.16 millionTranscript
3/15/2018Before Market$0.05$0.24$0.24$13.86 millionTranscript
11/14/2017Q3 2017($0.20)($0.24)($0.24)N/A
3/27/2017Q4 2016($0.16)($0.18)($0.18)Listen
11/10/2016Q3 2016($0.15)($0.12)($0.12)N/A
8/15/2016Q2 2016($0.20)($0.14)($0.14)Listen
5/13/2016Q1 2016($0.17)($0.21)($0.21)Listen
3/29/2016Q4 2015($0.23)($0.14)($0.14)Listen
11/12/2015Q3 2015($0.19)($0.29)($0.29)Listen
8/13/2015Q2 2015($0.19)($0.15)($0.15)Listen
5/12/2015Q1 2015($0.19)($0.15)($0.15)Listen
11/13/2014Q3 2014($0.41)($4.16)($4.16)Transcript
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 9/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.